Abstract: The present inventions include methods and compositions for detecting the presence of ions and measuring the level or concentration of ions in a sample by nuclear magnetic resonance (NMR) using magnetic particles. In particular, the inventions include the preparation and use of magnetic particles having synthetic ion chelators covalently bound to their surfaces. In the presence of target ions, the surface-modified magnetic particles form clusters, which can be monitored by NMR relaxation measurements. The relaxation times can then be used to detect specific ions and determine their concentration. The described methods, compositions, and devices are useful for a variety of applications including biomedical applications in diagnostics and imaging.

Abstract: A series of new bis(imino)pyridine vanadium(III) complexes was synthesized according to formula: They were tested for the homogeneous catalytic dimerization of propylene after activation with MAO and showed excellent selectivity for dimerization. The catalysts can be used with or without PPh3 as an additive to produce ?80% dimerized alkenes.

Abstract: The present invention relates to novel compounds that are useful as ligands in organometallic dyes. More particularly, the invention relates to dyes comprising the compounds, said dyes being sensitizing dyes useful in solar cell technology. According to an embodiment, the present invention discloses new ruthenium dyes and their application in dye-sensitized solar cells (DSC). The referred ruthenium dyes with new structural features can be easily synthesized, show more than 85% light-to-electricity conversion efficiency and a higher than 9% cell efficiency.

Abstract: The prostate-specific membrane antigen (PSMA) is increasingly recognized as a viable target for imaging and therapy of cancer. Various 99mTc/Re-labeled compounds were prepared by attaching known Tc/Re chelating agents to an amino-functionalized PSMA inhibitor with or without a variable length linker moiety. Ex vivo biodistribution and in vivo imaging demonstrated the degree of specific binding to engineered PSMA+ PC3 PIP tumors.

Abstract: The invention provides a dye-sensitized photovoltaic device which comprises: a first electrode; a second electrode; and, disposed between the first and second electrodes: an electron acceptor material which comprises a semiconductive metal oxide, a redox mediator material, and a photosensitizing dye which comprises a dendrimer of formula (I): [X]m-CORE-[[Y]p]-[DEN-DRON]]n wherein n, m, p, CORE, DENDRON, X and Y are as defined herein. The invention further provides a photosensitizing dye which is a dendrimer of formula (I), and the use, as a photosensitizing dye in a dye-sensitized photovoltaic device, of a compound which is a dendrimer of formula (T). Novel dendrimers of formula (T) are also provided. Novel catechol-based compounds are also provided. The catechol-based compounds can be used together with the dendrimers of formula (T) as the photosensitizing dyes in a photovoltaic device.

Abstract: Described herein are fluorinated organic compounds and methods of making fluorinated organic compounds, for example, using palladium complexes. Also described herein are compositions and kits containing compounds and palladium complexes described herein.

Abstract: Embodiments of the present invention are generally directed to compositions comprising a class of molecular probes for detecting the presence of anionic cell surfaces. Embodiments include compositions that are enriched for these compositions and preparations, particularly preparations suitable for use as laboratory/clinical reagents and diagnostic indicators, either alone or as part of a kit. An embodiment of the invention provides for a highly selective agent useful in the discernment and identification of dead or dying cells, such as apoptotic cells, in a relatively calcium-free environment. An embodiment of the invention provides a selective agent for the identification of bacteria in a mixed population of bacterial cells and nonbacterial cells.

Abstract: A photosensitizing transition metal complex of the formula (Ia) MLY1, (Ib) MLX3 (Ic) MLY2X, (Id) MLY3X or (Ie) MLY4X in which M is a transition metal selected from ruthenium, osmium, iron, rhenium and technetium, preferably ruthenium or osmium. X is a co-ligand independently selected from NCS—, Cl—, Br—, I—, CN—, H2O; pyridine unsubstituted or substituted by at least one group selected from vinyl, primary, secondary or tertiary amine, OH and C1-30 alkyl, preferably NSC and CN—; L is a tridentate polypyridine ligand, carrying at least one carboxylic, phosphoric acid or a chelating group and one substituted or unsubstituted alkyl group having 1 to 50 carbon atoms, substituted or unsubstituted alkylamide group having 2 to 30 carbon atoms or substituted or unsubstituted aralkyl group having 7 to 50 carbon atoms.

Abstract: A photosensitizing transition metal complex of the formula (Ia) MLY1, (Ib) MLX3 (Ic) MLY2X, (Id) MLY3X or (Ie) MLY4X in which M is a transition metal selected from ruthenium, osmium, iron, rhenium and technetium, preferably ruthenium or osmium. X is a co-ligand independently selected from NCS—, Cl—, Br—, I—, CN—, H2O; pyridine unsubstituted or substituted by at least one group selected from vinyl, primary, secondary or tertiary amine, OH and C1-30 alkyl, preferably NSC and CN—; L is a tridentate polypyridine ligand, carrying at least one carboxylic, phosphoric acid or a chelating group and one substituted or unsubstituted alkyl group having 1 to 50 carbon atoms, substituted or unsubstituted alkylamide group having 2 to 30 carbon atoms or substituted or unsubstituted aralkyl group having 7 to 50 carbon atoms.

Abstract: An organic radiation-emitting component such as an organic light emitting diode (OLED), having at least two electrode layers and, between them, at least one organic self-emitting layer with a phosphorescence triplet emitter comprising as well as one phosphorescent metal complex. The radiation-emitting layer contains, embedded in a matrix, a metal complex, preferably a transition metal complex, with at least one substituted or unsubstituted guanidinate ligand.

Abstract: The present invention discloses single site catalyst systems having anionic scorpion-like three dimensional structure, that are suitable for oligomerising or polymerising ethylene and alpha-olefins.

Abstract: The present invention relates to a method for the preparation applicable on large scale of sensitizer dyes conventionally used in dye-sensitized solar cells. Furthermore, methods for verifying the purity of the sensitizer dyes are disclosed.

Abstract: The present invention provides a method for measuring a surface plasmon resonance, the method enabling easy detection of the existence of a phosphorylated peptide (protein) and determination whether a peptide is phosphorylated or not in biological materials. The present invention also provides a noble metal compound having high capability of coordination to a phosphorylated peptide, and being conveniently usable in the method. A first method for measuring surface plasmon resonance of the present invention comprises: placing a noble metal compound on a bottom face of a prism, irradiating a light to the prism to detect a reflected light, wherein, the noble metal compound has substituents of following formula (I) on a side opposite to a side contacting the prism, and a subject sample is added to a side having the substituent groups (I) in the noble metal compound.

Abstract: [Problem] The present invention aims to provide a novel organometallic compound that can be used as a general-use highly active catalyst with superior selectivity for functional groups. [Means for Solving Problem] The present invention relates to an organometallic compound having a novel specific structure of general formula (1): and to a general-use highly active catalyst used in reductive amination reaction with superior selectivity for functional groups that comprises said organometallic compound, and to a process for preparing amine compounds by reductive amination reaction using said catalyst.

Abstract: The invention provides ruthenium-comprising catalysts, and methods of making and using them, for conjugating double bonds in polyunsaturated hydrocarbons, including polyunsaturated fatty acid derivatives, such as natural fats and oils which comprise (contain) more than one carbon to carbon double bond—where the double bonds are separated by, e.g., a methylene, ethylene or propylene or longer group. The invention provides compositions and methods for treating fats and oils comprising “interrupted” (e.g., “methylene-, ethylene- or propylene-interrupted”) double bonds to generate isomers with “conjugated” double bonds. The invention also provides compositions, and methods of making and using them, for making catalysts on a solid support. In one aspect, these catalysts are for alkene isomerization or exchange of alkene hydrogens for other isotopes.

Abstract: Novel ?-diimine metal complexes, particularly iron complexes, having a phenyl sulfidyl or substituted phenyl sulfidyl metal complexing group are disclosed. The ?-diimine metal complexes having a phenyl sulfidyl or substituted phenyl sulfidyl metal complexing group are produced by forming one of the ?-diimine metal complex imine bonds in the presence of a metal salt or an ?-acylimine metal complex. The ?-diimine metal complexes having phenyl sulfidyl or substituted phenyl sulfidyl metal complexing group are useful for polymerizing or oligomerizing olefins.

Abstract: A dye including an anchoring group in its molecular structure, said anchoring group allowing a covalent coupling of said dye to a surface, for example a surface of a nanoporous semiconductor layer, said anchoring group being represented by formula 1 wherein attachment of said anchoring group within said molecular structure of said dye is at the terminal carbon marked with an asterisk in above formula, wherein G is selected from —COOH, —SO3H, —PO3H2, —BO2H2, —SH, —OH, —NH2, preferably —COOH, wherein A is selected from the group comprising H, —CN, —NO2, —COOR, —COSR, —COR, —CSR, —NCS, —CF3, —CONR2-OCF3, C6H5-mFm, wherein m=1-5, R being H or any straight or branched alkyl chain of general formula —CnH2n+I, n=O-12, preferably 0-4, or any substituted or non-substituted phenyl or biphenyl.

Abstract: The invention relates to the use of carbon monoxide (CO) to treat infections. The invention also provides novel carbon monoxide releasing molecules (CORMs).

Abstract: A process for making diphosphine-ruthenium-diamine complexes by reacting a phosphine compound with an arene ruthenium compound in a first solvent to produce an intermediate mixture comprising a diphosphine-ruthenium compound, the first solvent consisting essentially of a mixture of an aprotic solvent and a protic solvent; then removing the first solvent from the intermediate mixture to produce an intermediate solid comprising the diphosphine-ruthenium compound; and then contacting the intermediate solid comprising the diphosphine-ruthenium compound with a diamine and a second solvent to produce the diphosphine-ruthenium-diamine complex, the second solvent consisting essentially of an aprotic solvent selected from the group consisting of ethers and hydrocarbon solvents.

Abstract: A compound of Formula I, a pharmaceutically acceptable salt, or solvate thereof: complexes with metals such as rhenium, technetium, and others to provide a complex for imaging tissues or treating disease, particularly where the metal is radioactive. Such complexes are specific to PSMA protein and can therefore be used in imaging or treating cancer of the prostate and other tissue where the protein is expressed.

Abstract: A compound that recognizes and binds to the CA-IX protein has Formula I, II, III, or IV. The compounds may include a radioactive element for radioimaging or therapeutic applications. Thus, pharmaceutical compositions may be prepared with one or more of the compounds of Formula I, II, III, or IV.

Abstract: Cobaloxime derivatives and methods of producing cobaloxime derivatives are disclosed herein. Methods of producing decolorized homo- and co-polymers through polymerization of monomers in presence of the cobaloxime derivatives and decolorization of the produced polymer by exposing the polymer to a sorbent and, optionally, a solvent are also disclosed herein.

Abstract: To provide a method of producing Prussian blue-type metal complex nanoparticles without necessarily requiring complicated steps and an excessive amount of raw materials, but allowing one to obtain nanometer-size fine particles having desired fine particle properties, and Prussian blue-type metal complex nanoparticles obtained by the method, a dispersion of the nanoparticles, a method of regulating the color of the nanoparticles, and an electrode and a transmitted light-regulator each using the nanoparticles; Prussian blue-type metal complex nanoparticles are produced by: mixing an aqueous solution containing a metal cyano complex anion having predetermined metal atom MA as a central metal and an aqueous solution containing a cation of predetermined metal atom MB, thereby precipitating the crystal of a Prussian blue-type metal complex having the metal atom MA and the metal atom MB; and then mixing the Prussian blue-type metal complex with an aqueous solution containing a metal cyano complex anion having the me

Abstract: Various methods, compounds and apparatus for the detection of analytes are provided. In one aspect, the direct oxidation of an alcohol is detected electrochemically. In another aspect, a reaction of an analyte is detected, wherein the reaction is catalysed by an enzyme and a cofactor, and wherein the cofactor comprises a moiety which is capable of acting as an electron mediator. In a further aspect, a chiral analyte is detected by resolving a enantiomeric mixture of the analyte and subsequently detecting at least one of the resolved enantiomers electrochemically. The invention is particularly relevant to the detection of alcohols, especially chiral alcohols.

Abstract: The present invention provides a complex compound (I) obtained by coordinating a ligand represented by the formula (II) below and a bidentate ligand to a metal atom, wherein, in the formula, Y1 and Y2 each independently represent a group containing an unsaturated aliphatic hydrocarbon and an aromatic ring; R1 and R2 each independently represent a salt of an acidic group or an acidic group; A represents a group containing a nitrogen atom, an oxygen atom, a carbon atom, a silicon atom, a sulfur atom or a selenium atom; and m, a, and b each independently represent an integer of 0 to 2, while satisfying a+b?1.

Abstract: Novel radiopharmaceuticals that are useful in diagnostic imaging and therapeutic treatment of disease characterized by overexpression of seprase include complexes that contains a proline moiety and a radionuclide adapted for radioimaging and/or radiotherapy:

Abstract: The present invention relates to a ruthenium complex represented by the following formula (I): RuL2(NCS)2Am ??(I) wherein L, A and m are defined the same as the specification, and a photoelectric component using the same. The ruthenium complex of the present invention can be used in a Dye-Sensitized Solar Cell (DSSC). Hence, the photoelectric characteristics of the DSSC manufactured with the ruthenium complex of the present invention can be improved.

Abstract: A photosensitizer dye is provided and it is a ruthenium-based complex represented by formula (1): wherein X1 is one of formulae (2) to (7) and X2 is hydrogen (H) or the same as X1; and wherein Y1 is hydrogen, lithium (Li), sodium (Na) or a tetra-alkyl ammonium group represented by formula (8), and Y2 is hydrogen or the same as Y1.

Abstract: The present invention relates to a ruthenium complex and a photoelectric component using the same, and the ruthenium complex is represented by the following formula (I): RuL2(NCS)2Am??(I) wherein L, A and m are defined the same as the specification. The ruthenium complex of the present invention is suitable for Dye-Sensitized Solar Cell (DSSC). Hence, the photoelectric characteristics of the DSSC manufactured with the ruthenium complex of the present invention can be improved.

Abstract: The present invention relates to a ruthenium-type dye and a making method thereof, and more particularly, to a ruthenium-type dye which is used to manufacture a dye-sensitized solar cell, drastically improves a molar extinction coefficient to enhance efficiency of a solar cell with only a small amount of a dye and oxide semiconductor particles, allows a thin film solar cell element to be manufactured without difficulty and sharply reduces manufacturing costs of a solar cell, and a making method thereof.

Abstract: Disclosed herein are a di-(4-vinylpyridine) metal phthalocyanine compound in which 4-vinylpyridines as ligands are included in a phthalocyanine having a metal, a composition comprising the same and a preparation method thereof. The di-(4-vinylpyridine) metal phthalocyanine compound has an excellent UV blocking effect together with low surface resistance and is prepared but by charging a powder phase with nitrogen, not by dissolving raw materials in an organic solvent as in the prior art.

Abstract: The present invention relates to specific, novel tantalum and niobium compounds which can serve as starting materials for the preparation of chemical vapour deposition (CVD) precursors.

Abstract: Pyridyldiamido transition metal complexes are disclosed for use in alkene polymerization. The ligands are tridentate with an NNN configuration.

Abstract: The present invention relates to novel compounds of formula (I) and (II), compositions comprising compounds of formula (II) and their use as contrast agents in magnetic resonance (MR) imaging (MRI) and MR spectroscopy (MRS).

Abstract: There are provided a novel compound which captures a multisite phosphorylated peptide or protein specifically to a phosphorylation site and a method for detecting a multisite phosphorylated peptide or protein using the same. In particular, there are provided a compound which specifically detects an excessively phosphorylated tau protein observed in the brain affected by Alzheimer's disease and a method for diagnosing Alzheimer's disease in vitro or in vivo using the compound.

Abstract: A theme of the present invention is to provide a new transition metal complex, useful as a photosensitizer dye for a photoelectric conversion element having an excellent durability and a high photoelectric conversion characteristic. The present invention provides a bivalent transition metal complex constituted of (i) a bipyridyl polyacidic ligand, such as a dicarboxybipyridyl (dcbpy) ligand, as an adsorption site for adsorption onto titanium dioxide particle surfaces; (ii) a ligand, selected from the group consisting of an isothiocyanato group, an isocyanato group, and an isoselenocyanato group and enabling absorption and excitation at long wavelengths and charge transfer; and (iii) a bipyridyl (bpy) ligand, having an alkyl group or an alkoxy group, preferably a long-chain alkyl group, and a conjugately bonded thienylvinylene group, aminophenylenevinylene group, et.

Abstract: A photosensitizer dye is provided. The photosensitizer dye is a ruthenium (Ru) complex represented by the following general formula (1). X1 represents one of formula (2) to (19) and X2 represents hydrogen, or X1 and X2 both represent one of formula (2) to (19). Z1 represents one of formula (38) to (44), and Z2 represents hydrogen or one of formula (38) to (44) or a group the same as Z1.

Abstract: A photosensitizer dye is provided. The photosensitizer dye is a Ru complex as formula (1): wherein X1 represents one of formula (2)˜(18) and X2 represents hydrogen atom or X1 and X2 both represent one of formula (2)˜(18), wherein Z1 represents one of formula (35)˜(41) and Z2 represents hydrogen atom or one of formula (35)˜(41) or a group the same with Z1.

Abstract: The present invention relates to transition metal compounds of the formula (I); where M is an element of group 3, 4, 5, 6, 7, 8, 9 or 10 of the Periodic Table of the Elements or the lanthanide's, the radicals X are identical or different and are each an organic or inorganic radical, with two radicals X also being able to be joined to one another to form a divalent radical, is 1, 2, 3 or 4, L1 is an organic or inorganic uncharged ligand, is an integer from 0 to 4, R1 is an organic radical having from 1 to 40 carbon atoms, R2 is hydrogen or an organic radical having from 1 to 40 carbon atoms, or R1 and R2 together form a divalent organic group T1 which has from 2 to 40 carbon atoms and together with the atoms connecting its ends forms a monocyclic or polycyclic ring system which may in turn be substituted and may comprise one or more further heteroatoms selected from the group consisting of the elements O, S, Se, Te, N, P and As in the ring system, R3 is hydrogen or an organic radical having from 1 to 40 carbon

Abstract: In one embodiment, the present invention relates generally to a method for separating olefins from paraffins. In one embodiment, the method includes providing a mixture comprising olefins and paraffins, providing a gas separation agent to associatively, reversibly and selectively bind the olefin and dissociating the olefin from the gas separation agent.

Abstract: Novel dyes, as well as related photovoltaic cells, components, systems, and methods, are disclosed.

Abstract: Process for the preparation of monoimine compounds, wherein a dicarbonyl compound is reacted in an aliphatic, non-aromatic solvent with aniline. Monoimine compounds having electron-withdrawing substituents in the ortho position and unsymmetric bis(imino) compounds and unsymmetric iron complexes prepared therefrom and the use thereof in the polymerization of olefins.

Abstract: Problem: To provide an optical recording medium having a recording layer improved in light stability that is capable of writing and reading of high-density optical information by a short-wavelength laser beam. Means for Solving the Problems: There is provided an optical recording medium with a recoding layer comprising an organic dye compound, wherein the recording layer contains a metal complex compound composed of a pyridone azo compound represented by the following the general formulas [I] to [III] and a divalent ion of metal coordinated to it such as nickel, cobalt, iron, zinc, copper, manganese and the like, wherein the pyridone azo compound contains a 6-hydroxy-2-pyridone structure as a coupling component and isoxazole, 1,2,4-triazole or pyrazole structure as a diazo component. (In the general formulas [I] to [III], R1 to R10 each is independently a hydrogen atom or monovalent functional group.

Abstract: A dye sensitized solar cell, comprising a-heteroleptic polypyridil complex of Ru, Os or Fe. The donating ligand has an extended conjugated n-system increasing the light absorbance and keeing the LUMO energy level higher than that of the anchoring ligand. A compacting compound whose molecular structure comprises a terminal group, a hydrophobic part and an anchoring? group may be co-adsorbed together with the dye on the semi-conductive metal oxide layer of the photoanode, forming a dense mixed self-assembled monolayer.

Abstract: The invention relates to bifunctional conjugates comprising a receptor ligand moiety and a metal binding moiety and complexes thereof with paramagnetic lanthanide or transition metals, and to the use of the metal complexes as contrast agents in magnetic resonance imaging (MRI) of tumors and other abnormalities.

Abstract: The invention relates to a new class of ruthenium (II) complexes containing as ligands 2-(aminomethyl)pyridines and phosphines, proven to be extremely active catalysts in the reduction of ketones to alcohols via hydrogen transfer. By using 2-propanol as the hydrogen source with the ruthenium complexes, high yields of the corresponding alcohol can be rapidly obtained starting from linear and cyclic alkyl aryl, dialkyl and diaryl ketones. The conversion of ketones to alcohols can reach 100% if operating in a gaseous hydrogen atmosphere (2-3 atm). Where the phosphines used are optically active, starting from prochiral ketone compounds various types of optically active alcohols can be produced, being important intermediates in the pharmaceutical industry, in the agrochemical industry and for fine chemicals generally.

Abstract: Iron, cobalt, chromium or vanadium complexes of 2,6-pyridinedicarboxaldehydes diimines and 2,6-diacylpyridines diimines which are suitable for catalyzing the oligomerization of ethylene to ?-olefins exhibit more prolonged catalytic activity if aryl groups attached to the imino carbon atom(s) are substituted with at least one nitro group.

Abstract: A tert-alkyl ketone, pinacolone was hydrogenated under pressurized hydrogen in the presence of a ruthenium complex (S)-1 and a base, and corresponding (S)-3,3,-dimethyl-2-butanol was thereby obtained in 100% yield and 97% ee

Abstract: A new ligands that include a benzene ring in the backbone can be combined with a metal or metal precursor compound or formed into a metal-ligand complex catalyze a number of different chemical transformations, including olefin polymerization reactions. The ligands, complexes formed with the ligands and compositions including the ligands are useful catalysts, depending on the reaction.

Abstract: The present invention relates to novel hexacoordinated metathesis catalysts and to methods for making and using the same. The inventive catalysts are of the formula wherein: M is ruthenium or osmium; X and X1 are the same or different and are each independently an anionic ligand; L, L1′ and L2 are the same or different and are each independently a neutral electron donor ligand; and, R and R1 are each independently hydrogen or a substituent selected from the group consisting of C1-C20 alkyl, C2-C20 alkenyl, C2-C20 alkynyl, aryl, C1-C20 carboxylate, C1-C20 alkoxy, C2-C20 alkenyloxy, C2-C20 alkynyloxy, aryloxy, C2-C20 alkoxycarbonyl, C1-C20 alkylthio, C1-C20 alkylsulfonyl and C1-C20 alkylsulfinyl and silyl.